Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pos is done nothing to see here anymore smh
Whoops, GC, hadn't seen your post when I posted the link- you beat me to it!
Sales news will be soon
Applied DNA Awarded Extension of Health Services Contract with The City University of New York
- Period of Performance Extended Through July 2023 at Prior Terms -
- Recognizes safeCircle’s™ Superior Integrated COVID-19 Testing and Vaccine Policy Management with Rapid Results Reporting and Campus Access Control -
- Mitigates Risk in the New Academic Year Given Surge in Variant Positivity Rates -
August 09, 2022 11:30 AM Eastern Daylight Time
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in polymerase chain reaction (“PCR”)-based technologies, today announced that The City University of New York (CUNY), the largest urban university in the United States, has extended its health services contract for COVID-19 testing and vaccine policy management with the Company’s wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), for 12 months through July 2023 and at the prior contract terms. ADCL’s COVID-19 testing volumes, including the CUNY contract, fueled the Company’s record fiscal 2021 revenues and consecutive quarterly record revenues in the first half of fiscal 2022 ended March 31, 2022.
“Given our infrastructure and client concentration in New York City, we are pleased to continue servicing CUNY while we expand our test offering and services.”
Tweet this
The contract has been successfully operational since August 2021. Through a partnership with Cleared4 software platform, ADCL provides a wide range of COVID-19 related health services to help CUNY mitigate COVID-19 associated risks. These services, which are provided to CUNY’s 25 campuses and covering 300,000+ students, employees, auxiliary workers, contractors and visitors, include: (i) high-throughput RT-PCR COVID-19 testing (weekly testing and a robust randomized testing program); (ii) vaccination policy and documentation management; and, (iii) facility access control.
“We commend the CUNY Board of Trustees for taking a forward-thinking approach to ensure the continued health and safety of all CUNY stakeholders while remaining committed to the promise and value of in-person learning. As New York City grapples with a resurgence of infections fueled by the Omicron BA.5 subvariant that can potentially elude rapid test detection and more easily reinfect people, including those who have been vaccinated, boosted and/or previously infected, our ability to deliver rapid PCR-based results with actionable reporting and access management for safeCircle clients remains a standout,” stated Dr. James A. Hayward, president and CEO of Applied DNA. “Given our infrastructure and client concentration in New York City, we are pleased to continue servicing CUNY while we expand our test offering and services.”
About safeCircle™
safeCircle is a fully integrated health testing platform that offers a customized suite of services to institutions and their personnel/members that encompasses: program design, RT-PCR and rapid antigen testing, sample kit distribution and collection, test site management, results reporting to individuals and program administrators, facilities access management, variant tracking, and vaccination documentation management.
Click to learn more: https://adnas.com/covid-19-testing-platform/
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the manufacture of DNA for use in nucleic acid-based therapeutics; (ii) the detection of DNA in molecular diagnostics testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.
The Company's common stock is listed on NASDAQ under the ticker symbol 'APDN,' and its publicly traded warrants are listed on OTC under the ticker symbol 'APPDW.'
Forward-Looking Statements
The statements made by Applied DNA in this press release may be "forward-looking" in nature within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe Applied DNA's future plans, projections, strategies, and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to its history of net losses, limited financial resources, limited market acceptance, the possibility that Applied DNA's assay kits or testing services could become obsolete or have their utility diminished and the unknown amount of revenues and profits that will results from Applied DNA's testing contracts. Further, the uncertainties inherent in research and development, future data and analysis, including whether any of Applied DNA's or its partner's future diagnostic candidates will advance further in the research process or receiving authorization, clearance or approval from the FDA, equivalent foreign regulatory agencies and/or the New York State Department of Health (NYSDOH), and whether and when, if at all, they will receive final authorization, clearance or approval from the FDA, equivalent foreign regulatory agencies and/or NYSDOH, the unknown outcome of any applications or requests to FDA, equivalent foreign regulatory agencies and/or the NYSDOH, the unknown limited duration of any EUAs from the FDA, changes in guidance promulgated by the CDC, FDA, CMS an/or NYSDOH relating to COVID-19 testing, disruptions in the supply of raw materials and supplies, continued mutations of the SARS-CoV-2 virus, shifting review priorities of FDA for COVID-19 EUA requests and when, if at all, any EUA request will be reviewed by FDA, and various other factors detailed from time to time in Applied DNA's SEC reports and filings, including our Annual Report on Form 10-K filed on December 9, 2021, its Quarterly Report on Form 10-Q filed on February 10, 2022, and May 12, 2022, and other reports we file with the SEC, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, unless otherwise required by law.
Contacts
Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Program: Mike Munzer, 631-240-8814, mike.munzer@adnas.com
Web: www.adnas.com
Twitter: @APDN
Wainwright is the outfit that did the offering.
Let’s see what happens today! This is ready for its next leg up
AH also low volume... maybe people are waiting cautiously for the CC on Thursday before committing more cash here.
Getting ready for its next leg up to $12+
Based on they might get FDA approval for their monkeypox PCR test. Look at the chart pattern also.
It’s almost ready for the next leg up to $12+
Bounced off the session low of 4.55
I agree. Nothing goes up in a straight line. Nothing goes down in a straight line.
Correction under way. Needs to find a new support level.
Looks like the shorts are making bank. Wainwright is a sleaze ball outfit. A pump operation.
Huge news! HC wainwright just raised their prediction for APDN from $4 to $8 because we are the only legit PCR monkeypox test in the USA! https://m.thefly.com/new-landing/3561676
This is going over $12 this week. Maybe even $20, $30 Remeber this has a tiny OS and almost no float. Doesn’t take that much pressure to make it rocket
Your going to trust a video from a guy from India that day trades the stock and is hoping the price comes down so he can re enter?? Hahahah this is going to $20
ADON is the top voted monkeypox stock on Twitter. https://twitter.com/deutschetrader/status/1556333290621005824?s=21&t=gbA0GUplyau2Xin-rKFf8Q
Cool off? Lol you shorts are desperate. Monkeypox is getting worse by the day. This will keep printing $$$
Yup oh well
#APDN ?? Time to cool off? What are price ranges it needs to hold? Chart analysis
$20 easily. Think more like $50-100
We will know in the fullness of time. We know the company has developed a test to identify the presence of the monkeypox virus. Next step is to produce it for distribution. This would obviously require additional operating capital, so the 14 million share offering makes sense in that respect. No one wants to see a spread outside of the gay community into the general population. We know the transmission is due to skin-on-skin contact, which, it goes without saying, occurs during sexual intercourse. Some of the stories about gay men who have the disease and are unable to get treatment is indeed disheartening. Critics of the CDC are saying it hasn't acted quickly enough, and I thoroughly agree. Michael Lewis' recent book, The Premonition, is a scathing account about how the CDC has become a multi-layered bureaucracy that was totally unprepared to quickly contain the Covid virus once it entered the US population.
That said, it is imperative the company act as quickly as possible to produce testing kits for distribution to the health care providers. But, given how government works these days, it may be too late. The virus, in my view. will eventually escape into the general population.
Obviously the recent development has generated a great deal of emotion about the company's stock. We will see how long this emotion can be sustained.
this one to $20+ Monk?
Less than 30 minutes to the Gaucho Market when it’s Mano a Mano trading. Get ready.
Check the current pps, now. Back under $6. Like I said, nothing goes up, nothing goes down in a straight line.
Let's discuss the current monkeypox situation in the US. A couple nights ago, The Daily, a podcast produced by the New York Times for National Public Radio invited its health reporter to update listeners about the spread. According to her, 99 percent of current cases are in the gay community, with a quarter of cases nationwide in New York. This is due to the propensity for gay men to have multiple sex partners. It is imperative that these men get regularly tested. If the virus, which isn't fatal but nonetheless causes painful symptoms, leaps into the general population, then look out.
President Biden needs to declare the current outbreak a national health emergency. Currently, doctors have to spend up to three hours filing out complicated paperwork to have people tested for the presence of the virus so that it can remain contained within the gay community.
If it wasn’t for idiots like you this would be over $50 right now. You cheap scapes trying to squeeze Pennys out of a stock like that are just dumb. If you’d let it run and stop trying to short it everytime it went up your make way more. Your a traitor
Read that post I made more closely. I said I would cover and make a bank, and then go long, which I did. Been trading it since the news caused that price eruption, as well as other four monkeypox plays.
The price can easily decline again. Nothing goes up. Nothing goes down. In a straight line.
Let’s burn this idiot short! Have fun losing everything here. Fair warning this is going to $50-100 you’ll owe your broker so much money on that cover call you’ll have to sell your house! What a fool
You idiot it’s up 10% how is your short position making bank?? Hahahha what a fcking clown. You lost all your money I bet! Hahah short interest is almost 600% idiot!!
Lol I’d be sweating if I were him
How is that shorting going for you now?
Get ready warming up for a nice squeeze on shorts….
Dilution is still dilution. My short position this morning is making bank. When the time comes to go long, I will buy back.
Trading 101
OLD NEWS. Why do you keep posting the same comment. Almost like you a short trying to scare people. They filed an S1MEF which means they can only add 20% to their additional offering that was completed over a week ago. It literally doesn’t mean shit if they add a few million more shares. We get over 100M volume everyday those will get bot up with 10 mins of market open hahaha, if your so scared sell, literally doesn’t mean shit, this is going to moon!
Same group of idiots rinsing and repeating. Working all day rinsing For only 20% profit for haha. They’ll be crying like babies when this gamma squeezes up to $50-100 hahah
The company filed a notice of effect Aug 4 to sell 14 million shares.
Read: dilution
Inexperienced traders taking profit for their beer money today, makes me laugh, they’d rather make some money to go have fun for the weekend than leave it in and potentially change their life and 20-40x it. Easy hold here! Worth $50-100 at min IMO
Followers
|
219
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
58919
|
Created
|
02/20/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |